For Investors | Psomagen

Company Announcements

March 29, 2024

Financial Statement & Consolidated Financial Statement - FY2023

March 21, 2024

20th Annual Report - FY2023

March 21, 2024

20th Audited Financial Report - FY2023

March 21, 2024

20th Audited Consolidated Financial Report - FY2023

March 14, 2024

Notice of convening the 20th Annual Shareholders’ Meeting

March 31, 2023

Statement of Financial Position - FY2022

March 23, 2023

19th Audited Financial Report - FY2022

March 23, 2023

19th Annual Report - FY2022

March 3, 2023

Notice of Convening the 19th Annual Shareholder's Meeting

June 20, 2022

19th Special Shareholders Meeting

March 31, 2022

Statement of Financial Position - FY2021

March 23, 2022

18th Annual Report - FY2021

March 23, 2022

18th Audited Financial Report - FY2021

March 16, 2022

18th Annual Shareholders Meeting

March 31, 2021

Statement of Financial Position - FY2020

March 23, 2021

Annual Report - FY 2020

March 23, 2021

Audited Financial Report - FY2020

March 2, 2021

17th Annual Shareholders Meeting

February 16, 2021

Regulations for KOSDAQ-listed Corporations

November 30, 2020

17th Annual Special Shareholders Meeting

July 13, 2020

Psomagen Stocks Up on 1st Day of KOSDAQ Listing

October 10, 2019

Deposit Agreement with KSD

Have an Investment Inquiry?

U.S. PHONE

Korean Phone

+82-2-2180-7489

EMAIL

kim19@psomagen.com Hyeong-tae Kim (김형태 부장) General Manager, IR Department

Let Us Know